ATE522601T1 - Varianten von antithrombin iii - Google Patents

Varianten von antithrombin iii

Info

Publication number
ATE522601T1
ATE522601T1 AT03756385T AT03756385T ATE522601T1 AT E522601 T1 ATE522601 T1 AT E522601T1 AT 03756385 T AT03756385 T AT 03756385T AT 03756385 T AT03756385 T AT 03756385T AT E522601 T1 ATE522601 T1 AT E522601T1
Authority
AT
Austria
Prior art keywords
antithrombin iii
variants
compositions
disclosed
antithrombin
Prior art date
Application number
AT03756385T
Other languages
English (en)
Inventor
Susan Bock
Adrian Hobden
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Application granted granted Critical
Publication of ATE522601T1 publication Critical patent/ATE522601T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03756385T 2002-05-31 2003-06-02 Varianten von antithrombin iii ATE522601T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38459902P 2002-05-31 2002-05-31
PCT/US2003/017506 WO2003101398A2 (en) 2002-05-31 2003-06-02 Variants of antithrombin iii

Publications (1)

Publication Number Publication Date
ATE522601T1 true ATE522601T1 (de) 2011-09-15

Family

ID=29712063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756385T ATE522601T1 (de) 2002-05-31 2003-06-02 Varianten von antithrombin iii

Country Status (6)

Country Link
US (1) US7482139B2 (de)
EP (1) EP1530629B1 (de)
AT (1) ATE522601T1 (de)
AU (1) AU2003243381A1 (de)
CA (1) CA2487901A1 (de)
WO (1) WO2003101398A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070259809A1 (en) * 2004-01-09 2007-11-08 Bock Susan C Methods of Using High Affinity Atiii Variants
CA2664844A1 (en) * 2006-10-06 2008-10-23 Celtaxsys, Inc. Chemorepulsion of cells
JP5764499B2 (ja) * 2009-01-16 2015-08-19 ユニベルシテ パリ サッド １１Ｕｎｉｖｅｒｓｉｔｅ Ｐａｒｉｓ Ｓｕｄ １１ 変異アンチトロンビン、その製造方法及び薬剤としての使用
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
EP2598652A4 (de) 2010-07-29 2014-04-30 Shire Human Genetic Therapies Tests zum nachweis von glykosaminoglykanen
EP2809796A4 (de) * 2012-02-01 2016-08-17 Shire Human Genetic Therapies Tests zum nachweis von glykosaminoglykanen
PE20160533A1 (es) 2013-03-14 2016-06-09 Bayer Healthcare Llc Anticuerpos monoclonales contra antitrombina beta que forma complejos con heparina
CN117567597B (zh) * 2024-01-17 2024-03-22 成都艾科斯伦医疗科技有限公司 一种抗凝血酶Ⅲ及抗Xa活性检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901917A1 (de) 1989-01-24 1990-07-26 Behringwerke Ag Mutanten von humanem antithrombin iii
EP0460072B1 (de) 1989-02-23 1998-02-04 Center For Blood Research, Inc. Menschlicher elastase-inhibitor
IE902276A1 (en) * 1989-06-26 1991-01-16 Akzo Nv Serpin variants
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
JP3479539B2 (ja) 1992-04-10 2003-12-15 エーザイ株式会社 ヒトアンチトロンビンｉｉｉ変異体
EP0714308A4 (de) 1993-08-26 1998-07-29 Univ California Methode, zusammensetzungen und vorrichtungen zur verabreichung von nackten polynukleotiden, welche für biologisch aktive peptide kodieren
US5843705A (en) 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
WO1999058098A2 (en) * 1998-05-12 1999-11-18 Bock Susan C HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO

Also Published As

Publication number Publication date
EP1530629B1 (de) 2011-08-31
WO2003101398A8 (en) 2005-03-17
AU2003243381A1 (en) 2003-12-19
US20060259987A1 (en) 2006-11-16
US7482139B2 (en) 2009-01-27
WO2003101398A2 (en) 2003-12-11
EP1530629A4 (de) 2007-11-07
AU2003243381A8 (en) 2003-12-19
CA2487901A1 (en) 2003-12-11
EP1530629A2 (de) 2005-05-18

Similar Documents

Publication Publication Date Title
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
EA200870019A1 (ru) Лактамовые соединения и способы их применения
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
ATE520674T1 (de) Natriumkanalblocker
BRPI0414599A (pt) pirrol-indóis substituìdos
ATE471324T1 (de) Triazolophthalazine
DE60319364D1 (de) Substituierte pyrroline als kinase inhibitoren
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
ATE484508T1 (de) Furylverbindungen
MX337059B (es) Metodos y composiciones para modular la hemostasia.
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
DE602004031372D1 (de) Nachweis von staphylococcus
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
DE602004009824D1 (de) Analyse von massenspektraldaten in den ruhigen gebieten
ATE522601T1 (de) Varianten von antithrombin iii
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
DE60329326D1 (de) Tace inhibitoren
EA200401032A1 (ru) Антиинфарктные молекулы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties